Publicly traded drug developers sold more than $13 billion of shares in the fourth quarter, the most in more than four years.
Read More from Technology – WSJ.com
Funding for Risky Biotechs Is Returning
Wednesday, January 14
Publicly traded drug developers sold more than $13 billion of shares in the fourth quarter, the most in more than four years.
Read More from Technology – WSJ.com